News

The Schwartz Center for Compassionate Healthcare, a Boston-based nonprofit dedicated to strengthening the relationship between patients and their healthcare providers, today announced it has received a $500,000 grant from the Amgen Foundation. This grant...

GSK has submitted US and EU regulatory applications seeking approval of a quadrivalent influenza vaccine for the "active immunisation of adults and children from 3 years of age for the prevention of influenza disease caused by influenza virus...

Galapagos NV and Servier, a private research based pharmaceutical company,  have announced the achievemen milestones under their alliance agreement in osteoarthritis. These milestones trigger payments to Galapagos totalling €3.5 million, which will contribute to the company’s 2011 financial results....

Essentialis Inc., a San Diego-based pharmaceutical company focused on the development of breakthrough medicines targeted to the ATP-sensitive potassium channel, has filed two new patent applications expanding the patent portfolio claiming its investigational triglyceride-lowering compound DCCR and new methods...

Bristol-Myers Squibb Company, a global biopharmaceutical company, and Pfizer announced that the US Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application for Eliquis for the prevention of stroke and...

Dainippon Sumitomo Pharma Co., Ltd has reached an agreement to acquire Norwood, Massachusetts-based biotechnology company, Boston Biomedical Inc. Under the terms of the agreement, DSP will make an upfront payment of US$ 200 million to...

Inclinix, a US-based contract research organisation (CRO) that provides customised solutions for patient enrolment to Phase I-IV clinical trials, has raised its profile in Eastern and Western Europe through a formal strategic partnership with JSW Life Sciences, a...